Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
Back to event

Color Additive Petition From the International Association of Color Manufacturers; Request To Amend the Color Additive Regulations To Remove the Solvents Methylene Chloride, Trichloroethylene, and Ethylene Dichloride

By Human Services Department, Food, Health, Drug Administration · Nov 9, 2026, 11:00 PM CST

Read full article at Federal Register
The Food and Drug Administration (FDA or we) is partially granting a color additive petition submitted by the International Association of Color Manufacturers (IACM or petitioner), by amending our color additive regulations, on the basis of abandonment, to remove the authorized uses of methylene chloride, trichloroethylene, and ethylene dichloride from the list of authorized extraction solvents fo

Excerpt shown under fair-use limits. Full text remains with the original publisher.

People in this coverage

Explore their history and attributable record. Being mentioned does not imply endorsement.

Layer 1 · Claims & fact checks

AI analysis

Layer 2 · Biblical perspective

Biblical interpretation
HOLY / RIGHTEOUS
Read the biblical analysis

Layer 3 · Reporting analysis

AI analysis

ProceduralThe language frames the FDA action as a procedural response to a petition, emphasizing the legal basis (abandonment) for the amendment.

JustificationThe statement supplies a justification for the regulatory change, citing the petitioner’s evidence.

Mootness ClaimThe agency characterizes the request as moot because the authorization had already been removed, reinforcing the finality of prior regulatory action.

Context

AI analysis

Missing context

The notice does not explain why the petitioner sought removal of these solvents, what health or safety concerns motivated the petition, or the broader regulatory implications of the changes.

Important context

The FDA’s action is based on the petitioner’s evidence of permanent abandonment of the solvent uses and on prior regulatory action (Delaney Clause) that had already removed methylene chloride as a diluent for fruit‑and‑vegetable marking inks.

Opinion vs. reporting

AI analysis

The document is a factual regulatory announcement; it contains no opinion, only reporting of agency actions and the petitioner’s data.